冻融胚胎移植:黄体在预防产科并发症中的潜在重要性
冻融胚胎移植(FET)技术改善使活产率提高,但FET周期与妊娠期高血压疾病风险增加相关,原因未明。近期证据提示黄体缺失可能部分解释该风险。一项前瞻性队列研究显示,程序化FET周期(无黄体)与改良自然FET周期相比,子痫前期及伴严重特征子痫前期发生率更高。黄体不仅产生雌二醇和孕酮,还产生松弛素和血管内皮生长因子等血管活性物质,程序化周期中未被替代,可能对初始胎盘形成重要。 emerging证据还揭示程序化FET周期相比自然FET周期其他不良产科和围产结局,包括产后出血、巨大儿和过期产。尽管FET广泛使用,但就活产率、母体健康和围产结局而言的最佳方案尚未确定,未来实践应基于高质量证据包括严格对照试验。
要点
- 程序化FET周期无黄体,与子痫前期及伴严重特征子痫前期风险增加相关。
- 黄体产生松弛素和VEGF等血管活性物质,程序化周期未替代,可能影响胎盘形成。
- 程序化FET周期还与其他不良结局相关,如产后出血、巨大儿和过期产。
核心结论
- 黄体缺失可能部分解释FET周期中妊娠期高血压疾病风险增加。
- 程序化FET周期相比改良自然或自然FET周期与更多不良产科和围产结局相关。
- FET最佳方案尚未确定,需高质量对照试验证据。
研究设计与样本
- 综述性文章,总结近期前瞻性队列研究及 emerging证据。
- 引用的前瞻性队列研究比较程序化FET周期(无黄体)与改良自然FET周期。
主要发现
- 程序化FET周期(无黄体)相比改良自然FET周期,子痫前期及伴严重特征子痫前期发生率更高。
- 程序化FET周期相比自然FET周期,产后出血、巨大儿和过期产等不良结局 specifically 被揭示。
- 黄体产生雌二醇、孕酮、松弛素和血管内皮生长因子,程序化周期中血管活性物质未被替代。
临床怎么用
- 临床应考虑黄体在FET周期中对预防产科并发症的潜在作用。
- 未来FET实践应基于高质量证据,包括严格对照试验。
局限性
- FET最佳方案尚未确定,需更多高质量证据。
- 黄体缺失与不良结局的关联基于观察性证据,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The use of frozen-thawed embryo transfer (FET) has increased over the past decade with improvements in technology and increasing live birth rates. FET facilitates elective single-embryo transfer, reduces ovarian hyperstimulation syndrome, optimizes endometrial receptivity, allows time for preimplantation genetics testing, and facilitates fertility preservation. FET cycles have been associated, however, with an increased risk of hypertensive disorders of pregnancy for reasons that are not clear. Recent evidence suggests that absence of the corpus luteum (CL) could be at least partly responsible for this increased risk. In a recent prospective cohort study, programmed FET cycles (no CL) were associated with higher rates of preeclampsia and preeclampsia with severe features compared with modified natural FET cycles. FET cycles are commonly performed in the context of a programmed cycle in which the endometrium is prepared with the use of exogenous E2 and P. In these cycles, ovulation is suppressed and therefore the CL is absent. The CL produces not only E2 and P, but also vasoactive products, such as relaxin and vascular endothelial growth factor, which are not replaced in a programmed FET cycle and which are hypothesized to be important for initial placentation. Emerging evidence has also revealed other adverse obstetrical and perinatal outcomes, including postpartum hemorrhage, macrosomia, and post-term birth specifically in programmed FET cycles compared with natural FET cycles. Despite the widespread use of FET, the optimal protocol with respect to live birth rate, maternal health, and perinatal outcomes has yet to be determined. Future practice regarding FET should be based on high-quality evidence, including rigorous controlled trials.
引用
- Singh B, Reschke L, Segars J, et al. Frozen-thawed embryo transfer: the potential importance of the corpus luteum in preventing obstetrical complications. Fertil Steril. 2020. PMID: 32106972. doi:10.1016/j.fertnstert.2019.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。